DRI
53
5
BF.B
33
2
AN
58
4
MHK
49
4
RIG
60
2
PBI
69
4
HON
67
2
CVX
47
3
DE
63
3
CMA
61
5
LB
63
22
NTAP
67
-3
EL
25
4
DG
6
2
RHI
59
2
PFG
45
3
HBI
59
4
VTR
47
-7
TXT
55
3
KMB
39
2
DRI
53
5
BF.B
33
2
AN
58
4
MHK
49
4
RIG
60
2
PBI
69
4
HON
67
2
CVX
47
3
DE
63
3
CMA
61
5
LB
63
22
NTAP
67
-3
EL
25
4
DG
6
2
RHI
59
2
PFG
45
3
HBI
59
4
VTR
47
-7
TXT
55
3
KMB
39
2
Financhill
Back

Regencell Bioscience Holdings 10K Form

Sell
24

RGC
Regencell Bioscience Holdings

Last Price:
5.88
Seasonality Move:
-1.47%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RGC News And Ratings

See the #1 stock for the next 7 days that we like better than RGC

RGC Financial Statistics

Sales & Book Value

Annual Sales: $3.16B
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.63
Price / Book: 9.29

Profitability

EPS (TTM): -0.33000
Net Income (TTM): $-4.3M
Gross Margin: $1.97B
Return on Equity: 0%
Return on Assets: 0%

Regencell Bioscience Holdings Earnings Forecast

Key Regencell Bioscience Holdings Financial Ratios

  • The Gross Profit Margin over the past 13 years for RGC is 62.33%.
  • The Selling, General & Administrative Expenses for RGC have been equal to 16.23% of Gross Profit Margin.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 19 years have been positive in 8 years.

Regencell Bioscience Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: RGC
Website: regencellbioscience.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

RGC Technical Analysis vs Fundamental Analysis

Sell
24
Regencell Bioscience Holdings (RGC) is a Sell

Is Regencell Bioscience Holdings a Buy or a Sell?